Common Contracts
5 similar License and Commercialization Agreement contracts by Valeant Pharmaceuticals International
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. AMENDMENT NO. FOUR TO LICENSE AND COMMERCIALIZATION AGREEMENT This AMENDMENT NO. FOUR...License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. (INTERMUNE (R) LOGO) December 31, 2004 Thomas D. Zindrick Vice President, Law Amgen...License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. AMENDMENT NO. THREE TO LICENSE AND COMMERCIALIZATION AGREEMENT This AMENDMENT NO....License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24B-2. LICENSE AND COMMERCIALIZATION AGREEMENT BY AND BETWEENLicense and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 240.24b-2. April 25, 2002 Mr. Brad Crawford Amgen Inc. One Amgen Center Drive Thousand Oaks, CA...License and Commercialization Agreement • March 16th, 2006 • Valeant Pharmaceuticals International • Pharmaceutical preparations
